.png)
🔑Could the key to overcoming deep-rooted wounds lie in the transformative power of psychedelics?!
Myles Katz has been at the forefront of the legal psychedelics for personal growth and healing since 2018. As the founder of one of the first legal psychedelic retreats in Amsterdam, which served over 1,000 clients before its closure one year ago. He is the founder of Confluence Retreats – where he facilitates nature-based, multi-modality legal psilocybin retreats in Oregon.
Psychedelic Research Results
MDMA for Trauma: Phase 3 clinical trials found 67% of participants no longer qualified for a PntTSD diagnosis after three months
Psilocybin for Adverse Childhood Experiences: Study found psilocybin lowered the impact of ACE's on psychological distress
Psilocybin for Alcohol Use Disorder: A study indicated that psilocybin-assisted therapy reduced heavy drinking days by approximately 83% among participants with alcohol dependence
Psilocybin for Depression: Study found 54% of participants were considered in remission four weeks post-treatment – meaning they no longer qualified as being depressed
Comments